Infliximab Therapeutic Mixture from United States
A mixed immunological preparation containing infliximab monoclonal antibodies for autoimmune diseases. It is in bulk form with excipients and not in measured doses or retail packings, fitting the tariff item.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is in bulk form without retail packaging
• Provide stability data for the mixture
• Verify if the product needs a Clinical Trial Application